VST Tillers Tractors Issues Postal Ballot Notice for Re-appointment of Dr. Nandakumar Jairam as Independent Director
V.S.T. Tillers Tractors Limited has issued a postal ballot notice for the re-appointment of Dr. Nandakumar Jairam (DIN: 00321693) as an Independent Director for a second term of five years from June 21, 2026, to June 20, 2031 (both days inclusive). The e-voting period runs from May 19, 2026, at 9:00 a.m. to June 17, 2026, at 5:00 p.m., with the cut-off date for shareholder eligibility set at May 08, 2026. The re-appointment has been recommended by the Nomination, Compensation and Remuneration Committee and the Board, based on Dr. Jairam's performance evaluation and his expertise in general management, sustainability, and corporate governance. His last drawn sitting fees for FY26 stood at Rs. 3,50,000/-.

*this image is generated using AI for illustrative purposes only.
V.S.T. Tillers Tractors Limited has issued a postal ballot notice, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, seeking shareholder approval for the re-appointment of Dr. Nandakumar Jairam (DIN: 00321693) as an Independent Director. The proposal, arising from a board meeting held on May 15, 2026, seeks to appoint Dr. Jairam for a second consecutive term of five years, commencing June 21, 2026, and ending June 20, 2031 (both days inclusive). The resolution is to be passed as a Special Resolution through the postal ballot process conducted exclusively via remote e-voting.
Re-appointment Proposal at a Glance
The following table summarises the key details of the proposed re-appointment:
| Parameter: | Details |
|---|---|
| Director Name: | Dr. Nandakumar Jairam |
| DIN: | 00321693 |
| First Term: | June 21, 2021 to June 20, 2026 |
| Proposed Second Term: | June 21, 2026 to June 20, 2031 (both days inclusive) |
| Resolution Type: | Special Resolution |
| E-Voting Start: | May 19, 2026 at 9:00 a.m. (IST) |
| E-Voting End: | June 17, 2026 at 5:00 p.m. (IST) |
| Cut-off Date: | May 08, 2026 |
| Last Drawn Sitting Fees (FY26): | Rs. 3,50,000/- |
| Shareholding in the Company: | 50 nos of shares |
| Board Meetings Attended (FY26): | 4 |
Profile of Dr. Nandakumar Jairam
Dr. Nandakumar Jairam is a distinguished healthcare leader, renowned surgeon, and visionary administrator with over four decades of experience in India's medical and healthcare sectors. His career includes serving as Chairman, CEO, and Group Medical Director of Columbia Asia Hospitals in India, where he played a pivotal role in the organisation's growth. He has also held significant positions such as Chairman of the National Accreditation Board for Hospitals and Healthcare Providers (NABH) under the Quality Council of India (QCI), Chairman of the Health Services Committee of FICCI, and member of the Health Insurance Forum of IRDA.
Dr. Jairam's contributions to healthcare have been recognised with several accolades, including the FRCS in 2017, the Healthcare Personality of India award by FICCI in 2017, and the Lifetime Achievement Award by FICCI in Healthcare in 2021. He holds qualifications of MBBS and MS in General Surgery, and was born on September 26, 1952.
Board and Committee Memberships
Dr. Jairam's current and external board engagements are as follows:
| Affiliation: | Committee Memberships |
|---|---|
| VST Tillers Tractors Limited: | Nomination Compensation & Remuneration Committee; Stakeholders Relationship Committee; Corporate Social Responsibility Committee |
| Aditya Birla Health Insurance Co. Limited: | Risk Management Committee; Nomination and Remuneration Committee; Policy holders Protection Committee |
| Eye Foundation Limited: | Audit Committee; Nomination and Remuneration Committee |
Basis for Re-appointment
The Nomination, Compensation and Remuneration Committee (NCRC), after evaluating Dr. Jairam's performance during his first term, has recommended his re-appointment for a second term of five years. The Board is satisfied with the outcome of the performance evaluation and has taken into account his diverse skill set, leadership capabilities, and expertise in areas including general management, sustainability, and corporate governance. The Board has confirmed that Dr. Jairam meets the criteria of independence as prescribed under Section 149(6) of the Companies Act, 2013, and Regulation 16(1)(b) of the SEBI LODR Regulations, 2015.
It is also noted that Dr. Nandakumar Jairam will attain the age of 75 years during his second term, specifically on September 26, 2027. Accordingly, the resolution also seeks shareholder approval for his continuation beyond that date, as required under Regulations 17(1A) and 25(2A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
E-Voting Process and Key Dates
The e-voting for this postal ballot is facilitated through the National Securities Depository Limited (NSDL) platform. Members holding shares as on the cut-off date of May 08, 2026—either in physical or dematerialised form—are entitled to cast their votes electronically. The results of the postal ballot will be declared within two working days from the conclusion of the e-voting period, i.e., by June 17, 2026, and will be communicated to the stock exchanges and displayed on the Company's website at www.vsttractors.com . Mr. Thirupal Gorige (Membership No. FCS 6680/CP No. 6424), Designated Partner of M/s. Thirupal Gorige & Associates LLP, Bengaluru, has been appointed as the Scrutinizer to oversee the process in a fair and transparent manner.
Historical Stock Returns for VST Tillers Tractors
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.92% | -7.77% | -14.90% | -16.17% | +19.80% | +146.90% |
How might Dr. Nandakumar Jairam's healthcare expertise influence V.S.T. Tillers Tractors' future ESG and corporate sustainability strategies, given the company's primarily agricultural focus?
What succession planning measures is V.S.T. Tillers Tractors likely to consider given that Dr. Jairam will reach the mandatory age-related regulatory threshold of 75 during his proposed second term in 2027?
How could institutional shareholders and proxy advisory firms respond to the re-appointment vote, particularly regarding the age-continuation clause requiring special approval under SEBI LODR Regulations 17(1A) and 25(2A)?


































